Cardiomyopathy epidemiology and demographics
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy epidemiology and demographics |
|
Risk calculators and risk factors for Cardiomyopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Incidence and prevalence differ based on cause. The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized. The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population. RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.
Cardiomyopathy Epidemiology and Demographics
Incidence and prevalence differ based on cause.[1]
- The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.[2]
- The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population.[3]
- RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.
References
Template:Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997; 336:267. Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373:1289. Template:WS Template:Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331:1564.
- ↑ Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M (May 2003). "Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy". Circulation. 107 (17): 2227–32. doi:10.1161/01.CIR.0000066323.15244.54. PMID 12707239.
- ↑ Kushwaha SS, Fallon JT, Fuster V (January 1997). "Restrictive cardiomyopathy". N. Engl. J. Med. 336 (4): 267–76. doi:10.1056/NEJM199701233360407. PMID 8995091.
- ↑ Kawasaki K, Miyaji K, Kodera S, Suzuki Y, Kanda J, Ikeda M (May 2015). "Arrhythmogenic right ventricular cardiomyopathy in a patient with schizophrenia". Clin Case Rep. 3 (5): 308–14. doi:10.1002/ccr3.230. PMID 25984311.